This inventor holds 1 USPTO granted patent and 3 published patent applications and 5 EPO patents. Top assignee: Vaxon Biotech. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Kostantinos Kosmatopoulos: Innovator in Anti-Cancer Vaccines
Introduction
Kostantinos Kosmatopoulos is a notable inventor based in Paris, France. He has made significant contributions to the field of anti-cancer vaccines through his innovative research and development.
Latest Patents
His most recent patent is titled "Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof." This invention focuses on an optimized polypeptide that includes three cryptic tumor peptides with enhanced immunogenicity. The amino acid sequence YLQVNSLQTVYLEYRQVPVYLEEITGYL (SEQ ID NO. 2) is crucial for its application in anti-cancer vaccines. Additionally, the patent encompasses nucleic acids encoding this polypeptide, as well as engineered dendritic cells and complexes that utilize this innovative polypeptide.
Career Highlights
Kostantinos has worked with prominent companies in the biotechnology sector, including Vaxon Biotech and Kriptic Pharmaceuticals Limited. His work has been instrumental in advancing the development of effective cancer treatments.
Collaborations
He has collaborated with notable professionals in his field, including Sébastien Cornet and Jeanne Menez-Jamet. These partnerships have contributed to the success of his research and innovations.
Conclusion
Kostantinos Kosmatopoulos is a pioneering inventor whose work in anti-cancer vaccines is making a significant impact in the medical field. His innovative approaches and collaborations continue to drive advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile